国邦医药集团股份有限公司 2025年第一季度报告

Core Viewpoint - The announcement emphasizes the commitment of the company's board and management to ensure the accuracy and completeness of the quarterly report, asserting that there are no false statements or significant omissions [2][3]. Financial Data Summary - The financial statements for the first quarter of 2025 are unaudited, with the company confirming that there were no profits from mergers under common control for the current and previous periods, both recorded as 0 yuan [3][5]. - The report includes a consolidated balance sheet and cash flow statement for the period from January to March 2025, also unaudited [5]. Shareholder Information - There is no applicable information regarding the total number of ordinary shareholders or changes in the top ten shareholders due to the absence of relevant data [4]. Other Important Reminders - The company has indicated that there are no additional significant operational updates or reminders for investors regarding the reporting period [4][5].